Personalised Medicine in sarcoma: molecular subtypes drive treatment

Half of sarcomas show molecular alterations and more than 10 molecular subtypes now allow to be treated with a more personalised or targeted approach. In this short ESMO video, Jean-Yves Blay discusses several histological subtypes of sarcoma where personalised medicine has already become a standard. What is needed is the organization of properly annotated tumour banks; reliable molecular diagnostic strategies in network centres; education of investigators and physicians to understand the crucial importance of biology-driven treatment. Watch the video here.